A number of cytokines are active durihg the evolution of an inflammatory response, including tumor necrosis factor-o, interleukin-1, and novel chemotactic cytokines. This latter group of mediators belong to supergene families of inflammatory signals that play a key role in the selective recruitment of immune cells. In this presentation, we present data demonstrating, for the fmt time, endothelial cell expression of monocyte chemotactic protein (MCP) mRNA induced by LPS, interleukin-1 or tumor necrosis factor. Human fibroblasts were also found to express monocyte chemotactic factor mRNA in response to interleukin-1 or tumor necrosis factor, but LPS was not effective. In addition, neither primary cultures expressed MCP in response to interleukin-6. These studies demonstrate that non-immune "bystan&?' cells can play an active role in the recruitment of inflammatory cells via the production of novel chemotactic cytokines.
A number of cytokines are active durihg the evolution of an inflammatory response, including tumor necrosis factor-o, interleukin-1, and novel chemotactic cytokines. This latter group of mediators belong to supergene families of inflammatory signals that play a key role in the selective recruitment of immune cells. In this presentation, we present data demonstrating, for the fmt time, endothelial cell expression of monocyte chemotactic protein (MCP) mRNA induced by LPS, interleukin-1 or tumor necrosis factor. Human fibroblasts were also found to express monocyte chemotactic factor mRNA in response to interleukin-1 or tumor necrosis factor, but LPS was not effective. In addition, neither primary cultures expressed MCP in response to interleukin-6. These studies demonstrate that non-immune "bystan&?' cells can play an active role in the recruitment of inflammatory cells via the production of novel chemotactic cytokines. The elicitation of leukocytes into various tissues constitutes a key element in the inflammatory response that is common to a variety of injurious conditions, including cancer, infection, and trauma. The events that lead to leukocyte elicitation and activation are complex, as various leukocyte populations must fmt adhere to the vascular endothelium and then undergo directed migration in response to a gradient of chemotactic factor(s).
Interestingly, the composition of the inflammatory cell infiltrate changes as the immune response evolves. It is apparent that selective chemoattractants must be synthesized in a coordinate manner in order for the normal cascade of cellular events to occur. Recent studies have identified novel chemotactic cytokines that may participate in this process via the selective recruitment of inflammatory cells (l-7). One of these cytokines is a neutrophil/lymphocyte chemotactic factor (l-4), while another is a monocyte chemotactic protein (MCP) (5-7).
Abbreviations used in this manuscript: MCP, monocyte chemotactic pmteim IL-l, interleukin-1; IL-6, interleukin-6 TNP, tumor necrosis facts, LPS, lipopolysaccharide. 
MATERIALS AND METHODS
CelI Powlations: Human endothelial cells were isolated from umbilical veins according to previously published procedures (8). The recovered endothelial cells were cultured in medium 199 supplemented with 100 ug/ml endothelial cell growth supplement, 20% fetal bovine serum, and 100 &ml bovine lung heparin. All cells in these studies were used prior to their fifth passage in culture. Primary human foreskin fibroblasts (4-8 passage) were grown to confluence in RPMI 1640 containing 1 mM glutamine, 25 mM HIVES, 100 units/ml penicillin, 100 u&ml streptomycin, plus 10% fetal calf serum. On the day of use, cells were washed and either cytokines or LPS were added for the specified times and doses. Reagents:
Human recombinant IL-lp with specific activity of 30 U/rig was the generous gift of the Upjohn Company. Human recombinant TNF-cz (20 U/rig, specific activity) was a gift of the Cetus Corporation. Human recombinant IL6 (20 U/ul) was purchased from Genzyme Inc. Lipopolysaccharide (011 l:B4) was purchased from Sigma (St. Louis, MO). Northern Blot Analysis:
Total endothelial cell RNA was extracted using a modification of the methods of Jonas er ul. (9) and Chirgwin el ul.(lO). The adherent endothelial cells were solubilized in a solution of 25 mM Tris, pH 8.0 containing 4.2 M guanidine isothiocyanate, 0.5% Sarkosyl, and 0.1 M beta-mercaptoethanol. After homogenization, an equal volume of 10 mM Tris, pH 8.0 containing 1.0% SDS and 10 mM EDTA was added and the RNA extracted with chloroform-phenol.
The alcohol pmipitated RNA was separated by formaldehyde/l% agarose gels and transblotted to nitrocellulose. The baked blots were prehybridized and then hybridized with a 32P-5-end-labeled 30-mer oligonucleotide probe. The probe was complementary to nucleotides 256-285 of published cDNA sequence for human monocyte chemotactic and activating factor/monocyte chemoattractant protein (5,6). The sequence of the probe was 5'-'ITG-GGT-m-CIT-GTC-CAG-GTG-GTC-CAT-GGA-3'.
Blots were stringency washed and autoradiographs were quantitated by laser densitometry. Equivalent amounts of total RNA load per gel lane were assessed by monitoring 28s and 18s rRNA. Mono&e Chemotactic Protein Assay: Human monocytes were prepared from peripheral blood by Ficoll-Hypaque density gradient centrifugation.
Monocytes were suspended at 2 x 106 cells/ml in phosphate-buffed saline containing 0.2% bovine serum albumin with greater than 95% viability. Chemotaxis was performed using a modification of the method of Harvath ef al. (11) . Briefly, 30 ul of diluted supmatant specimen, 10-7 M formyl methionylleucylphenaylalanine (fMLP, Sigma Chemical Co., St. Loui!, MO) or HBSS alone were placed in duplicate bottom well of a 48-well microchemotms chamber (Neuro probe, Cabin John, MD).
A 5 micron pore-size polycarbonate filter (polyvinylpyrolidone-free, Nucleopa, Corp.) was placed in the assembly ?nd 50. ~1 of monocyte suspension placed in each of the top wells. After incubating at 370C m hum&f&l 95% sir/5% CO2 for 2 hrs, the filters were removed, iixed in methanol, and stained with Diff-Quik (American Scientific Products, McGraw Park, IL) Monocytes that had migrated through the bottom of the filter were counted in 10 high power fields. Chemotactic activity was assessed as pement of the fMLP positive control. (14), and procoagulant-like activity (15). In addition, In further studies, we now demonstrate that both human primary cultured endothelial cells and fibroblasts can express a novel chemotactic cytokine with specificity for monocytes (monocyte chemotactic protein). Both IL-1 and TNF were effective in inducing the expression of MCP mRNA and bioactivity from flbroblasts and endothelial cells. The expression of MCP by these primary cultures was not a global response to all cytokines, as interleukin-6 was inactive in this system. Interestingly, LPS or cytokine-treated monocytes themselves did not produce MCP. These studies are important as they demonstrate that nonimmune "bystander" cells synthesize key mediators that participate in the orchestration of an immune response. The production of novel chemotactic cytokines by fibroblasts and endothelial cells, is especially noteworthy, as coordinated communication circuits between the interstitium and vascular bed may dictate the initiation and maintenance of inflammation.
